When the HPA axis is activated, CRF is released from the paraventricular nucleus(PVN) into the portal circulation, stimulating the pituitary to produce and release adrenocorticotropic hormone (ACTH)
For example, current phase 3 studies are investigating the effect of retatrutide in obese individuals with chronic diseases other than T2D: TRIUMPH-3 aims at recruiting individuals struggling with overweight or obesity, but who also have a history of heart attack, stroke, or peripheral arterial disease [28]
It is made to effectively cleanse the body while sanitizing it
As we age, NAD + levels decline , impacting energy production, cellular regeneration, and skin vitality
That really keeps us helping them optimize the trajectory of things. This is especially if you've stopped because your insurance stops covering GLP-1s